Strong Tower Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,497
Closed -$433K 102
2024
Q2
$433K Buy
+5,497
New +$451K 0.14% 84
2023
Q4
Sell
-13,370
Closed -$1.05M 92
2023
Q3
$1.05M Buy
13,370
+301
+2% +$25.2K 0.52% 45
2023
Q2
$1.15M Buy
13,069
+173
+1% +$14.9K 0.55% 45
2023
Q1
$1.04M Buy
12,896
+1,657
+15% +$135K 0.55% 45
2022
Q4
$873K Sell
11,239
-1,009
-8% -$81.8K 0.52% 48
2022
Q3
$989K Buy
12,248
+278
+2% +$25K 0.59% 45
2022
Q2
$1.07M Buy
11,970
+236
+2% +$23.9K 0.58% 49
2022
Q1
$1.3M Buy
11,734
+2,333
+25% +$246K 0.67% 39
2021
Q4
$973K Buy
9,401
+725
+8% +$84K 0.52% 55
2021
Q3
$1.06M Buy
+8,676
New +$1.12M 0.62% 41

Other funds holding MDT

Strong Tower Advisory Services's MDT Position: Q3 2024 in Review

Strong Tower Advisory Services sold out of Medtronic (MDT) in Q3 2024, closing a stake of 5,497 shares — an estimated $433K sold.

Strong Tower Advisory Services first reported a position in MDT in Q3 2021 and held it in 10 quarters. The position peaked at $1.3M in Q1 2022. 2,069 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Strong Tower Advisory Services reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • Strong Tower Advisory Services sold 5,497 Medtronic shares in Q3 2024, an estimated $433K.
  • Strong Tower Advisory Services first reported a position in Medtronic in Q3 2021 and held it in 10 quarters.
  • Strong Tower Advisory Services's Medtronic position peaked at $1.3M in Q1 2022.
  • 2,069 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Strong Tower Advisory Services's 13F filing for Q3 2024, filed 9 Oct 2024.